Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20038030HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20048589HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20026706HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20048288HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20033039HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20021233HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20032030HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44018639HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44021744HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44029331HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TCGA Plot Options
Drug Information
GeneCHRM3
DrugBank IDDB06787
Drug NameHexocyclium
Target IDBE0000045
UniProt IDP20309
Regulation Typeantagonist
PubMed IDs8075869
CitationsWaelbroeck M, Camus J, Tastenoy M, Feifel R, Mutschler E, Tacke R, Strohmann C, Rafeiner K, Rodrigues de Miranda JF, Lambrecht G: Binding and functional properties of hexocyclium and sila-hexocyclium derivatives to muscarinic receptor subtypes. Br J Pharmacol. 1994 Jun;112(2):505-14.
GroupsApproved
Direct ClassificationAralkylamines
SMILESC[N+]1(C)CCN(CC(O)(C2CCCCC2)C2=CC=CC=C2)CC1
Pathways
PharmGKB
ChEMBLCHEMBL1201325